CD8A and neoplasm: Cancer immunotherapy utilizes the host immune system, especially CD4+ and CD8+ T cells, to attack tumor cells with different approaches like immune checkpoint inhibitors (ICIs), immunomodulators, and cancer vaccines (7, 8).